Programmed Cell Death and Melatonin: A Comprehensive Review

Overview

Journal Funct Integr Genomics

Publisher Springer

Specialties Genetics
Molecular Biology

Date 2024 Sep 23

PMID 39313718

Authors

Mahdi Rafiyian

Russel J Reiter

Sayyed Mehdi Rasooli Manesh

Reza Asemi

Mehran Sharifi

Sotoudeh Mohammadi

Mohammad Ali Mansournia

Zatollah Asemi

Affiliations

Soon will be listed here.

Abstract

Melatonin (MLT), a main product of pineal gland, recently has attracted the attention of scientists due to its benefits in various diseases and also regulation of cellular homeostasis. Its receptor scares widely distributed indicating that it influences numerous organs. Programmed cell death (PCD), of which there several types, is a regulated by highly conserved mechanisms and important for development and function of different organs. Enhancement or inhibition of PCDs could be a useful technique for treatment of different diseases and MLT, due to its direct effects on these pathways, is a good candidate for this strategy. Many studies investigated the role of MLT on PCDs in different diseases and in this review, we summarized some of the most significant studies in this field to provide a better insight into the mechanisms of modulation of PCD by MLT modulation.

Citing Articles

Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting-A Comprehensive Review of Its Unusual Health Benefits.

Fornari Laurindo L, Simili O, Cressoni Araujo A, Landgraf Guiguer E, Direito R, Valenti V Biology (Basel). 2025; 14(2).

PMID: 40001911 PMC: 11851571. DOI: 10.3390/biology14020143.

References

Acuna-Castroviejo D, Escames G, Venegas C, Diaz-Casado M, Lima-Cabello E, Lopez L . Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014; 71(16):2997-3025. PMC: 11113552. DOI: 10.1007/s00018-014-1579-2. View

Andersen L, Gogenur I, Rosenberg J, Reiter R . The Safety of Melatonin in Humans. Clin Drug Investig. 2015; 36(3):169-75. DOI: 10.1007/s40261-015-0368-5. View

Arangino S, Cagnacci A, Angiolucci M, Vacca A, Longu G, Volpe A . Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. 1999; 83(9):1417-9. DOI: 10.1016/s0002-9149(99)00112-5. View

Arendt J . Melatonin: characteristics, concerns, and prospects. J Biol Rhythms. 2005; 20(4):291-303. DOI: 10.1177/0748730405277492. View

Arendt J . Melatonin and human rhythms. Chronobiol Int. 2006; 23(1-2):21-37. DOI: 10.1080/07420520500464361. View

Ashok B, Ajith T, Sivanesan S . Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease. Clin Exp Pharmacol Physiol. 2016; 44(3):327-334. DOI: 10.1111/1440-1681.12717. View

Axelrod J, Weissbach H . Enzymatic O-methylation of N-acetylserotonin to melatonin. Science. 1960; 131(3409):1312. DOI: 10.1126/science.131.3409.1312. View

Ayton S, Lei P, Duce J, Wong B, Sedjahtera A, Adlard P . Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol. 2013; 73(4):554-9. DOI: 10.1002/ana.23817. View

Bald E, Nance C, Schultz J . Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open-Access ALS Clinic Trials database. Muscle Nerve. 2021; 63(4):572-576. PMC: 8842494. DOI: 10.1002/mus.27168. View

10.

Bartness T, Demas G, Song C . Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med (Maywood). 2002; 227(6):363-76. DOI: 10.1177/153537020222700601. View

11.

Bejarano I, Redondo P, Espino J, Rosado J, Paredes S, Barriga C . Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res. 2009; 46(4):392-400. DOI: 10.1111/j.1600-079X.2009.00675.x. View

12.

Blask D, Dauchy R, Sauer L . Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005; 27(2):179-88. DOI: 10.1385/ENDO:27:2:179. View

13.

Blesa J, Przedborski S . Parkinson's disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2015; 8:155. PMC: 4266040. DOI: 10.3389/fnana.2014.00155. View

14.

Brugger P, Marktl W, Herold M . Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet. 1995; 345(8962):1408. DOI: 10.1016/s0140-6736(95)92600-3. View

15.

Bubenik G . Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002; 47(10):2336-48. DOI: 10.1023/a:1020107915919. View

16.

Burbulla L, Song P, Mazzulli J, Zampese E, Wong Y, Jeon S . Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science. 2017; 357(6357):1255-1261. PMC: 6021018. DOI: 10.1126/science.aam9080. View

17.

Carrillo-Vico A, Guerrero J, Lardone P, Reiter R . A review of the multiple actions of melatonin on the immune system. Endocrine. 2005; 27(2):189-200. DOI: 10.1385/ENDO:27:2:189. View

18.

Chang C, Huang H, Lee H, Hung K, Wu R, Lin A . Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α-synuclein aggregation. J Pineal Res. 2012; 52(3):312-21. DOI: 10.1111/j.1600-079X.2011.00945.x. View

19.

Chen T, Lee M, Chen H, Kuo Y, Lin S, Wu T . Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res. 2006; 40(3):242-50. DOI: 10.1111/j.1600-079X.2005.00307.x. View

20.

Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y . Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Oncol Rep. 2015; 33(3):1465-74. DOI: 10.3892/or.2015.3712. View